First the vaccine, now the cure…
Pfizer has officially begun human trials to test their COVID-19 treatment that will be produced in the form of a pill. The cure will be used to treat patients as soon as first signs of the illness appear to stop further ramifications of the virus from developing. If proven successful at trials, the medication will be prescribed to be taken twice a day for five days.
Today, we announced that we’ve started testing the safety profile of our novel oral #antiviral investigational drug candidate for SARS-CoV-2 infections. #COVID19 #ScienceWillWin https://t.co/ePS7tebQqW pic.twitter.com/VLuOXv0CX3— Pfizer Inc. (@pfizer) March 23, 2021
Pfizer is not the first or only pharma company to start working on a COVID-19 pill. Merck, a New Jersey-based company is already in advanced stages of testing a similar cure.